Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity
The use of doxorubicin (DOX) chemotherapy is restricted due to dose-dependent cardiotoxicity. Pyridoxamine (PM) is a vitamin B6 derivative with favorable effects on diverse cardiovascular diseases, suggesting a cardioprotective effect on DOX-induced cardiotoxicity. The cardioprotective nature of PM...
Saved in:
Main Authors: | Sibren Haesen (Author), Manon Marie Jager (Author), Aline Brillouet (Author), Iris de Laat (Author), Lotte Vastmans (Author), Eline Verghote (Author), Anouk Delaet (Author), Sarah D'Haese (Author), Ibrahim Hamad (Author), Markus Kleinewietfeld (Author), Jeroen Mebis (Author), Wilfried Mullens (Author), Ivo Lambrichts (Author), Esther Wolfs (Author), Dorien Deluyker (Author), Virginie Bito (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Complexes of Copper and Iron with Pyridoxamine, Ascorbic Acid, and a Model Amadori Compound: Exploring Pyridoxamine's Secondary Antioxidant Activity
by: Guillermo García-Díez, et al.
Published: (2021) -
The Impact of Advanced Glycation End-Products (AGEs) on Proliferation and Apoptosis of Primary Stem Cells: A Systematic Review
by: Lize Evens, et al.
Published: (2020) -
Pyridoxamine Supplementation Effectively Reverses the Abnormal Phenotypes of Zebrafish Larvae With PNPO Deficiency
by: Po-Yuan Chen, et al.
Published: (2019) -
Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation
by: Sarah Kassab, et al.
Published: (2019) -
How Does Pyridoxamine Inhibit the Formation of Advanced Glycation End Products? The Role of Its Primary Antioxidant Activity
by: Rafael Ramis, et al.
Published: (2019)